FDA Inspection 1093157 — NextPharma Ploermel
The FDA completed an inspection of NextPharma Ploermel on Apr 20, 2018 in Ploermel. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 20, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ploermel (France)
Additional Details
Mutual Recognition Agreement (MRA)